Atopic dermatitis

Lancet

Volumn 351, Issue 9117, 1998, Pages 1715-1721

  Rudikoff, Donald ^a   Lebwohl, Mark ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; AZATHIOPRINE; COAL TAR; CORTICOSTEROID; CYCLOSPORIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; IMMUNOGLOBULIN E ANTIBODY; PSORALEN; TACROLIMUS;

ABDOMINAL PAIN; ATOPIC DERMATITIS; BONE MARROW SUPPRESSION; CANCER; CELLULAR IMMUNITY; CLINICAL FEATURE; CLINICAL TRIAL; DIFFERENTIAL DIAGNOSIS; DROWSINESS; DRY SKIN; EOSINOPHIL; GASTROINTESTINAL SYMPTOM; GENETIC DISORDER; HEADACHE; HELPER CELL; HERPES SIMPLEX; HUMAN; HYPERTENSION; NEPHROTOXICITY; NEUTROPHIL; ORAL DRUG ADMINISTRATION; PAIN; PHOTOTHERAPY; PIGMENT DISORDER; PRIORITY JOURNAL; PRURITUS; REVIEW; SKIN ALLERGY; STAPHYLOCOCCUS INFECTION; T LYMPHOCYTE; TOPICAL DRUG ADMINISTRATION;

EID: 0032490342     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)12082-7     Document Type: Review

References (50)

1. 1 Hanifin JM. Atopic dermatitis. In: Middleton E, Reed CE, Ellis EF, Adkinson NF, Yunginger JW, Busse WW, eds. Allergy principles and practice, 4th edn. St Louis: Mosby, 1993: 1581-604.
2. 2 Thestrup-Pedersen K, Ellingsen AR, Olesen AB, Lund M, Kaltoft K. Atopic dermatitis may be a genetically determined dysmaturation of ectodermal tissue, resulting in disturbed T-lymphocyte maturation: a hypothesis. Acta Derm Venereol 1997; 77: 20-21.
3. 3 Cox HE, Moffatt MF, Faux JA, et al. Association of atopic dermatitis to the beta subunit of the high affinity immunoglobulin E receptor. Br J Dermatol 1998; 138: 182-82.
4. 4 Hanifin JM, Rakja G. Diagnostic features of atopic dermatitis. Acta Dermatovener 1980; 92 (suppl): 44-47.
5. 5 Aly R, Mailbach HI, Shinefield HR. Microbial flora of atopic dermatitis. Arch Dermatol 1977; 113: 780-82.
6. 6 Dahl RE, Bernhisel-Broadbent J, Scanlon-Holdford S, Sampson HA, Lupo M. Sleep disturbances in childen with atopic dermatitis. Arch Pediatr Adolesc Med 1995; 149: 856-60.
7. 7 Cooper KD. Atopic dermatitis: recent trends in pathogenesis and therapy. J Invest Dermatol 1994; 102: 128-37.
8. 8 Leung DYM. Atopic dermatitis: immunobiology and treatment with immune modulators. Clin Exp Immunol 1997; 107: 25-30.
9. 9 Leiferman AKM. Eosinophils in atopic dermatitis. J Allergy Clin Immunol 1994; 94: 1310-17.
10. 10 de Vries JE, Punnonen J. Regulation of the human IgE response by IL4 and IL13. Res Immunol 1993; 144: 597-601.
11. 11 Katagiri K, Itami S, Hatano Y, Takayasu S. Increased levels of IL-13 mRNA, but not IL-4 mRNA, are found in vivo in peripheral blood mononuclear cells (PBMC) of patients with atopic dermatitis. Clin Exp Immunol 1997; 108: 289-94.
12. 12 Van der Ploeg I, Jeddi Tehrani M, Matuseviciene G, et al. IL-13 over-expression in skin is not confined to IgE-mediated skin inflammation. Clin Exp Immunol 1997; 109: 526-32.
13. 13 Akdis M, Akdis CA, Weigl L, Disch R, Blaser K. Skin-homing, CLA+ memory T cells are activated in atopic dermatitis and regulate IgE by an IL-13-dominated cytokine pattern: IgG4 counter-regulation by CLA-memory T cells. J Immunol 1997; 159: 4611-19.
14. 14 Santamaria-Babi LF. Skin-homing T cells in human cutaneous allergic inflammation. Immunol Res 1995; 14: 317-24.
15. 15 Jung K, Imhof BA, Linse R, Wollina U, Neumann C. Adhesion molecules in atopic dermatitis: upregulation of alpha6 integrin expression in spontaneous lesional skin as well as in atopen, antigen and irritative induced patch test reactions. Int Arch Allergy Immunol 1997; 113: 495-504.
16. 16 Koide M, Furukawa F, Tokura Y, Shirahama S, Takigawa M. Evaluation of soluble cell adhesion molecules in atopic dermatitis. J Dermatol 1997; 24: 88-93.
17. 17 Abernathy-Carver KJ, Sampson HA, Picker LJ, Leung DY. Milk-induced eczema is associated with the expansion of T cells expressing cutaneous antigen. J Clin Invest 1995; 95: 913-18.
18. 18 Neuber K, Steinrucke K, Ring J. Staphylococcal enterotoxin B affects in vitro IgE synthesis, interferon-gamma, interleukin-4 and interleukin-5 production in atopic eczema. Int Arch Allergy Immunol 1995; 107: 179-82.
19. 19 Leung DY, Gately M, Trumble A, Ferguson-Darnell B, Schlievert PM, Picker LJ. Bacterial superantigens induce T cell expression of the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen, via stimulation of interleukin 12 production. J Exp Med 1995; 181: 747-53.
20. 20 Bengtsson A, Holm L, Back O, Fransson J, Scheynius A. Elevated serum levels of soluble CD30 in patients with atopic dermatitis. Clin Exp Immunol 1997; 109: 533-37.
21. 21 Nakazawa M, Sugi N, Kawaguchi H, et al. Predominance of type 2 cytokine-inducing CD4+ and CDS+ cells in patients with atopic dermatitis. J Allergy Clin Immunol 1997; 99: 673-82.
22. 22 Neumann C, Gutgesell C, Fliegert F, Bonifer R, Herrmann F. Comparative analysis of the frequency of house dust mite specific and nonspecific Th1 and Th2 cells in skin lesions and peripheral blood of patients with atopic dermatitis. J Mol Med 1996; 74: 401-06.
23. 23 Reekers R, Beyer K, Niggemann B, et al. The role of circulating food antigen-specific lymphocytes in food allergic childen with atopic dermatitis. Br J Dermatol 1996; 135: 935-41.
24. 24 Werfel T, Ahlers G, Schmidt P, Boeker M, Kapp A, Neumann C. Milk responsiveness atopic dermatitis is associated with a casein-specific lymphocyte response in adolescent and adult patients. J Allergy Clin Immunol 1997; 99: 124-33.
25. 25 Werfel T, Morita A, Grewe M, et al. Allergen specificity of skin-infiltrating T cells is not restricted to a type-2 cytokine pattern in chronic skin lesions of atopic dermatitis. J Invest Dermatol 1996; 107: 871-86.
26. 26 Hamid Q, Boguniewicz M, Leung DY. Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. J Clin Invest 1994; 94: 870-76.
27. 27 Hamid Q, Naseer T, Minshall EM, Song YL, Boguniewicz M, Leung DY. In vivo expression of IL-12 and IL-13 in atopic dermatitis. J Allergy Clin Immunol 1996; 98: 225-31.
28. 28 Thepen T, Langeveld-Wildschut EG, Bihari IC, et al. Biphasic response against aeroallergen in atopic dermatitis showing a switch from an initial Th2 response to a Rh1 response in situ: an immunocytochemical study. J Allergy Clin Immunol 1996; 97: 828-37.
29. 29 Ohki O, Yokozeki H, Katayama I, et al. Functional CD86 (B7-2/B70) is predominantly expressed on Langerhans cells in atopic dermatitis. Br J Dermatol 1997; 136: 838-45.
30. 30 Cheng JF, Ott NL, Peterson EA, et al. Dermal eosinophils in atopic dermatitis undergo cytolytic degeneration. J Allergy Clin Immunol 1997; 99: 683-92.
31. 31 Sampson HA. Food sensitivity and the pathogenesis of atopic dermatitis. J R Soc Med 1997; 90 (suppl): 2-8.
32. 32 Tupker RA, De Monchy JGR, Coenraads PJ, Homan A, van der Meer JB. Induction of atopic dermatitis by inhalation of house dust mite. J Allergy Clin Immunol 1996; 97: 1064-70.
33. 33 Clark RA, Adinoff AD. The relationship between positive aeroallergen patch test reactions and aeroallergen exacerbations of atopic dermatitis. Clin Immunol Immunopathol 1989; 53: S132-40.
34. 34 Langeveld-Wildschut EG, Thepen T, Bihari IC, et al. Evaluation of the atopy patch test and the cutaneous late-phase reaction as relevant models for the study of allergic inflammation in patients with atopic eczema. J Allergy Clin Immunol 1996; 98: 1019-27.
35. 35 Valenta R, Maurer D, Steiner R, et al. Immunoglobulin E response to human protiens in atopic patients. J Invest Dermatol 1996; 107: 203-08.
36. 36 Grewe SR, Chan SC, Hanifin JM. Elevated leukocyte cyclic AMP-phosphodiesterase in atopic disease: a possible mechanism for cyclic AMP-agonist hyporesponsiveness. J Allergy Clin Immunol 1982; 70: 452-57.
37. 37 Imokawa G, Abe A, Jin K, Higaki Y, Kawashima M, Hidano A. Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin? J Invest Dermatol 1991; 96: 523-26.
38. 38 Murata Y, Ogata J, Higaki Y, et al. Abnormal expression of sphingomyelin acylase in atopic dermatitis: an etiologic factor for ceramide deficiency? J Invest Dermatol 1996; 106: 1242-49.
39. 39 Seguchi T, Chang-Yi C, Kusuda S, Takahashi M, Aisu K, Tezuka T. Decreased expression of filaggrin in atopic skin. Arch Dermatol Res 1996; 288: 442-46.
40. 40 Resnick SD, Hornung R, Konrad TR. A comparison of dermatologists and generalists. Arch Dermatol 1996; 132: 1047-52.
41. 41 Tan BB, Weald D, Strickland I, Friedman PS. Double-blind controlled trial of effect of housedust-mite allergen avoidance on atopic dermatitis. Lancet 1996; 347: 15-18.
42. 42 Krutmann J. Phototherapy for atopic dermatitis. Dermatol Ther 1996; 1: 24-31.
43. 43 Campbell DE, Kemp AS. Proliferation and production of interferon-gamma and IL-4 in response to Staphylococcus aureus and staphylococcal superantigen in childhood. Clin Exp Immunol 1997; 107: 392-97.
44. 44 Berth-Jones J, Finlay AY, Zaki I, et al. Cyclosporine in severe childhood atopic dermatitis: a multicenter study. J Am Acad Dermatol 1996; 34: 1016-21.
45. 45 Berth-Jones J, Graham-Brown RA, Marks R, et al. Long term efficacy and safety of cyclosporin in severe adult atopic dermatitis. Br J Dermatol 1997; 136: 76-81.
46. 46 Buckley C, Poulter LW, Rustin MH. Immunohistological analysis of "negative" patch test sites in atopic dermatitis. Clin Exp Allergy 1996; 26: 1057-63.
47. 47 Lear JT, English JSC, Jones P, Smith AG. Retrospective review of the use of azathioprine in severe atopic dermatitis. J Am Acad Dermatol 1996; 35: 642-43.
48. 48 Tan BB. Azathioprine in dermatology: a survey of current practice in the UK. Br J Dermatol 1997; 136: 351-55.
49. 49 Ruzicka T, Bieber T, Schopf E, et al. A short-term trial of tacrolimus ointment for atopic dermatitis: European Tacrolimus Multicenter Atopic Dermatitis Study Group. N Engl J Med 1997; 337: 816-21.
50. 50 Alaiti S, Kang S, Fiedler VC, et al. Tacrolimus (FK506) ointment for atopic dermatitis: a phase I study in adults and children. J Am Acad Dermatol 1998; 38: 69-76.